Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Cardiac Myosin Acts Is a Potent Procoagulant in Vitro and In Vivo

Jevgenia Zilberman-Rudenko, Hiroshi Deguchi, MD PhD, Mohammed Hayat, Meenal Shukla, PhD, Jennifer Nagrampa Orje, Zihan Guo, Tine Wyseure, PhD, Laurent O Mosnier, Owen J T McCarty, PhD, Zaverio M. Ruggeri, MD, John H. Griffin, PhD

Blood (2019) 134 (Supplement_1): 3632.

https://doi.org/10.1182/blood-2019-129312

Published: 2019

Journal Articles

Prevention of Bleeding-Induced Vascular Abnormalities in the Hemophilic Mouse Joint By Increasing TAFI Levels or Inhibiting uPA Activity

Tine Wyseure, PhD, Niels Behrendt, Annette von Drygalski, MD PharmD, Laurent O Mosnier

Blood (2019) 134 (Supplement_1): 158.

https://doi.org/10.1182/blood-2019-128723

Published: 2019

Journal Articles

Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice

Miguel Alejandro Lopez-Ramirez, Angela Pham, Romuald Girard, Tine Wyseure, Preston Hale, Atsuki Yamashita, Janne Koskimäki, Sean Polster, Laleh Saadat, Ignacio A. Romero, Charles T. Esmon, Frederic Lagarrigue, Issam A. Awad, Laurent O. Mosnier, Mark H. Ginsberg

Blood (2019) 133 (3): 193–204.

https://doi.org/10.1182/blood-2018-06-856062

Published: 2019

Includes: Supplemental data

Journal Articles

Effects of Hemostasis Correction on Vascular Remodeling and Synovial Gene Expression Changes in Mice after Induced Hemarthrosis

Esther J Cooke, Jenny Y Zhou, Tine Wyseure, Srila Gopal, John Shimashita, Chanond A Nasamran, Kathleen M Fisch, Laurent O Mosnier, Annette von Drygalski

Blood (2018) 132 (Supplement 1): 1188.

https://doi.org/10.1182/blood-2018-99-119694

Published: 2018

Journal Articles

Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding

Tine Wyseure, Esther J. Cooke, Paul J. Declerck, Niels Behrendt, Joost C. M. Meijers, Annette von Drygalski, Laurent O. Mosnier

Blood (2018) 132 (15): 1593–1603.

https://doi.org/10.1182/blood-2018-01-828434

Published: 2018

Includes: Supplemental data

Journal Articles

Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke

Tine Wyseure, Marina Rubio, Frederik Denorme, Sara Martinez de Lizarrondo, Miet Peeters, Ann Gils, Simon F. De Meyer, Denis Vivien, Paul J. Declerck

Blood (2015) 125 (8): 1325–1332.

https://doi.org/10.1182/blood-2014-07-588319

Published: 2015

Includes: Supplemental data

NARROW

Cardiac Myosin Acts Is a Potent Procoagulant in Vitro and In Vivo

Prevention of Bleeding-Induced Vascular Abnormalities in the Hemophilic Mouse Joint By Increasing TAFI Levels or Inhibiting uPA Activity

Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice

Effects of Hemostasis Correction on Vascular Remodeling and Synovial Gene Expression Changes in Mice after Induced Hemarthrosis

Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding

Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke

Email alerts

ASH Publications

American Society of Hematology

Cardiac Myosin Acts Is a Potent Procoagulant in Vitro and In Vivo

Prevention of Bleeding-Induced Vascular Abnormalities in the Hemophilic Mouse Joint By Increasing TAFI Levels or Inhibiting uPA Activity

Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice

Effects of Hemostasis Correction on Vascular Remodeling and Synovial Gene Expression Changes in Mice after Induced Hemarthrosis

Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding

Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only